retatrutide safety profile clinical trials Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide Side Effects 2026

Researchers suspect they may curb reward-seeking behavior and reduce cravings for people struggling with things like alcohol, nicotine and opioids though were still quite a few years away from them being covered by insurance fort that purpose

Subcutaneous injections have a track record of safe use, but adherence and proper technique are essential for optimal results

50% of Gen Z and 40% of millennials have fewer or less painful periods when using GLP-1s

Unlike an acute rotator cuff tear, tendinopathy typically develops over time due to repetitive use, poor posture, age-related changes, or shoulder impingement